If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFS.L Regulatory News (AFS)

  • There is currently no data for AFS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed transfer of listing to TASE

28 Apr 2021 15:40

RNS Number : 9556W
Amiad Water Systems Ltd
28 April 2021
 

28 April 2021

 

Amiad Water Systems Ltd.

("Amiad" or the "Company")

 

Proposed transfer of listing to TASE

Proposed cancellation of admission of ordinary shares to trading on AIM

Proposed listing of ordinary shares on TASE

 

Amiad (AIM: AFS), a leading global producer of water treatment and filtration solutions, announces the proposed cancellation of the admission of the Company's ordinary shares of NIS 0.5 each ("Ordinary Shares") to trading on AIM (the "AIM Cancellation") and a proposed listing of the Company's Ordinary Shares to trading on the Tel Aviv Stock Exchange ("TASE") (the "TASE Listing"), which remains subject to a number of conditions including shareholder approval.

 

Following a careful review of the benefits and drawbacks of the Company's shares continuing to be admitted to trading on AIM and whether it should seek a listing on an alternative exchange, the board of directors of Amiad (the "Board") has concluded that a TASE Listing and simultaneous AIM Cancellation is likely to be in the best interests of both the Company and its shareholders as a whole. The Board believes that TASE is a more suitable platform for the Company's shares to be listed as it offers access to capital at significantly lower costs, as well as providing exposure to local funds and investors in Israel where the Company's headquarters are located. The Board remains committed to the Company continuing to remain a public company and for the Ordinary Shares to be traded on an internationally recognised stock exchange. It therefore intends to seek shareholder approval for the cancellation of the admission of its Ordinary Shares to trading on AIM conditional upon the TASE Listing becoming effective.

 

The Ordinary Shares will continue to be admitted to trading on AIM prior to the proposed AIM Cancellation and the TASE Listing. If the TASE Listing does not ultimately occur, the Company's Ordinary Shares are expected to continue to trade on AIM for the foreseeable future.

 

Circular and Extraordinary General Meeting

 

The Company intends to post a circular to shareholders (the "Circular") containing a notice to convene an extraordinary general meeting (the "EGM") to seek shareholder approval for the proposed AIM Cancellation conditional upon and simultaneous with the TASE Listing. The Circular will provide further information on the reasons for the proposed TASE Listing and AIM Cancellation, and will provide details of dealing and settlement arrangements.

 

The proposed AIM Cancellation will be conditional, pursuant to Rule 41 of the AIM Rules for Companies (the "AIM Rules"), upon the approval of not less than 75 per cent of the votes cast by shareholders (whether present in person or by proxy) at the EGM.

 

Timetable 

 

Under the AIM Rules, the Company is required to give at least 20 clear Business Days' notice of the proposed AIM Cancellation date. Additionally, the proposed AIM Cancellation will not take effect until at least five clear Business Days have passed following the passing of the proposed resolutions at an EGM to be summoned by the Company for that purpose.

 

The Company's current intention is to issue a circular to shareholders in June that will include a notice convening an EGM to be held in July. Subject to the receipt of the requisite approvals from shareholders and the Israel Securities Authority, the Company currently expects the proposed AIM Cancellation and the TASE Listing to become effective on the same day in early August. However, the Company cannot be certain at this stage as to whether such a timetable will be achievable.

 

Accordingly, the Company will announce definitive dates for the EGM and, ultimately, the TASE Listing and the AIM Cancellation as soon as it is in a position to do so.

 

The Company will update the market in due course.

 

This announcement contains inside information for the purposes of the Market Abuse Regulation (596/2014/EU) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for arranging for the release of this announcement on behalf of the Company is Dori Ivzori, Chief Executive Officer.

 

Enquiries

 

Amiad Water Systems Ltd.

 

Dori Ivzori, Chief Executive Officer

Relly Shimko, Chief Financial Officer

+972 4 690 9500

 

Stifel Nicolaus Europe Ltd.

 

Fred Walsh, Stewart Wallace

+44 20 7710 7600

 

Luther Pendragon

 

Harry Chathli, Claire Norbury

+44 20 7618 9100

  

 

About Amiad

 

Amiad Water Systems (AIM: AFS) is a leading global producer of automatic, self-cleaning water treatment and filtration products and systems. Through its engineering skills and ability to innovate, Amiad provides cost-effective "green" solutions for irrigation and industrial purposes. In these markets, its unique and high-quality products are being integrated into the core of systems for filtration and water treatment, micro irrigation and membrane protection, wastewater and potable water treatment, cooling systems and sea water filtration. Headquartered in Israel, Amiad provides these solutions through ten subsidiaries and a comprehensive network of distributors to customers in more than 80 countries.

 

FIMI Opportunity Funds, the leading private equity investor in Israel, is a controlling shareholder of Amiad, with an interest in 39.5% of the Company's outstanding issued share capital.

 

For additional information or product details, please visit www.amiad.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZVLFLFZLXBBQ
Date   Source Headline
25th Mar 20204:43 pmRNSSecond Price Monitoring Extn
25th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 202010:34 amRNSFurther update on EGM
20th Mar 20207:00 amRNSUpdate on EGM
4th Mar 20207:00 amRNSProposed Directorate Change
27th Feb 20207:00 amRNSUpdate on potential investment and Notice of EGM
11th Feb 20207:00 amRNSAmiad receives Green Economy Mark
2nd Jan 20204:25 pmRNSPDMR Exercise of Options, Issue of Equity and TVR
13th Dec 20197:00 amRNSTrading Update
12th Dec 201912:12 pmRNSResult of AGM
22nd Nov 20197:00 amRNSUpdate on Potential Investment
7th Nov 201912:50 pmRNSNotice of AGM, Options Grant & Directorate Change
11th Sep 20197:00 amRNSInterim Results
11th Sep 20197:00 amRNSUpdate on Potential Investment
2nd Sep 20198:54 amRNSResponse to Media Speculation
28th May 20197:00 amRNSPublication of Annual Report and Accounts
21st May 20197:00 amRNSDirectorate Change
7th May 20194:40 pmRNSSecond Price Monitoring Extn
7th May 20194:35 pmRNSPrice Monitoring Extension
7th May 201910:20 amRNSHolding(s) in Company
7th May 201910:20 amRNSHolding(s) in Company
28th Mar 20197:00 amRNSFinal Results
19th Mar 20197:00 amRNSAppointment of Chief Financial Officer
13th Nov 20187:00 amRNSManagement Change
6th Nov 20185:13 pmRNSSecond Price Monitoring Extn
6th Nov 20184:35 pmRNSPrice Monitoring Extension
13th Sep 201812:01 pmRNSResult of AGM and Director Appointment
5th Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSAmiad supplies major Singapore desalination plant
2nd Aug 20183:00 pmRNSNotice of AGM and Directorate Change
26th Jul 20183:48 pmRNSHolding(s) in Company
24th Jul 20182:05 pmRNSSecond Price Monitoring Extn
24th Jul 20182:00 pmRNSPrice Monitoring Extension
24th Jul 20187:00 amRNSAcquisition of Amiad India
23rd Jul 201812:38 pmRNSHolding(s) in Company
13th Jun 20184:44 pmRNSDeath of a Director
25th May 20189:00 amRNSPublication of Annual Report and Accounts
11th Apr 20187:00 amRNSFinal Results
3rd Apr 20187:00 amRNSDirectorate Change
28th Feb 201811:50 amRNSResult of EGM and Director Appointment
24th Jan 20183:30 pmRNSNotice of EGM and Directorate Change
22nd Nov 20172:55 pmRNSLicensing agreement with Dow Global Technologies
6th Sep 20177:00 amRNSInterim Results
3rd Aug 201711:37 amRNSResult of AGM
12th Jul 20177:00 amRNSUpdate regarding French certification
28th Jun 20178:30 amRNSNotice of AGM
31st May 20177:00 amRNSNotification regarding French certification
28th Apr 201711:51 amRNSPublication of Annual Report
30th Mar 20177:00 amRNSFinal Results
28th Feb 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.